However, several limitations exist
Pregnancy Safety and Treatment Timing While GLP-1 agents offer meaningful metabolic benefits, they are not recommended during pregnancy
Most available studies focus on oral semaglutide used alone for weight management
Less emotionally responsive
These events stimulate the secretion of insulin, helping to compensate for insulin resistance triggered by new-onset diabetes. The drug also suppresses glucagon release by the pancreas, resulting in glucose-dependent reduction in plasma glucose and postprandial glucose by inhibiting hepatic glucose production and delaying gastric emptying. GLP-1s also act in brain regions associated with appetite and reward, reducing food intake and promoting weight loss
ARC GABAergic neurons that express thyrotropin-releasing hormone (TRH), approximately 60% of which expressed GLP-1R, were found to have GABAergic afferents directly targeting AgRP neurons